VentriPoint Diagnostics Ltd.
VPTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $95 | $49 | $68 | $0 |
| % Growth | 93.5% | -27.8% | – | – |
| Cost of Goods Sold | $0 | $7 | $10 | $49 |
| Gross Profit | $95 | $42 | $58 | -$49 |
| % Margin | 100% | 86.3% | 84.8% | – |
| R&D Expenses | $969 | $1,084 | $1,050 | $457 |
| G&A Expenses | $2,567 | $2,809 | $3,064 | $2,673 |
| SG&A Expenses | $3,928 | $3,889 | $3,918 | $3,215 |
| Sales & Mktg Exp. | $1,361 | $1,081 | $820 | $542 |
| Other Operating Expenses | $0 | $0 | $0 | $43 |
| Operating Expenses | $4,897 | $4,973 | $4,969 | $3,715 |
| Operating Income | -$4,802 | -$4,930 | -$4,911 | -$3,715 |
| % Margin | -5,045.4% | -10,024.8% | -7,204% | – |
| Other Income/Exp. Net | -$201 | $59 | $38 | -$166 |
| Pre-Tax Income | -$5,003 | -$4,872 | -$4,873 | -$3,881 |
| Tax Expense | -$83 | $0 | $0 | $0 |
| Net Income | -$4,920 | -$4,872 | -$4,873 | -$3,881 |
| % Margin | -5,169.1% | -9,905.7% | -7,148.3% | – |
| EPS | -0.031 | -0.031 | -0.031 | -0.029 |
| % Growth | 0% | 0.3% | -9.5% | – |
| EPS Diluted | -0.031 | -0.031 | -0.031 | -0.029 |
| Weighted Avg Shares Out | 157,183 | 156,824 | 155,994 | 136,097 |
| Weighted Avg Shares Out Dil | 157,183 | 156,824 | 155,994 | 136,097 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $77 | $25 | $51 |
| Interest Expense | $180 | $58 | $28 | $13 |
| Depreciation & Amortization | $63 | $67 | $51 | $13 |
| EBITDA | -$4,760 | -$4,747 | -$4,794 | -$3,702 |
| % Margin | -5,002% | -9,651.4% | -7,032.3% | – |